Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer

BACKGROUND: Sarcopenia characterized by skeletal muscle loss may influence postoperative outcomes through physical decline and weakened immunity. We aimed to investigate clinical significance of sarcopenia in resected early-stage non-small cell lung cancer (NSCLC). METHODS: We retrospectively review...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Transl Med
Glavni autori: Takahashi, Yusuke, Suzuki, Shigeki, Hamada, Kenichi, Nakada, Takeo, Oya, Yuko, Sakakura, Noriaki, Matsushita, Hirokazu, Kuroda, Hiroaki
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2021
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944314/
https://ncbi.nlm.nih.gov/pubmed/33708952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-4380
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items